FDA Approved: INQOVI — Original Application (Taiho Pharmaceutical Co., Ltd.)

View source ↗

Summary

FDA approved INQOVI (cedazuridine and decitabine) from Taiho Pharmaceutical Co., Ltd. under an original NDA (NDA 212576) for adults with myelodysplastic syndrom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome
• Myelomonocytic Leukemia

Drugs mentioned

• Inqovi (decitabine/cedazuridine)

Snippet

ORIG AP for INQOVI (CEDAZURIDINE AND DECITABINE)